Terms: = Leukemia AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Treatment
91 results:
1. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
2. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
3. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
[TBL] [Abstract] [Full Text] [Related]
4. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic leukemia.
Oikonomou A; Valsecchi L; Quadri M; Watrin T; Scharov K; Procopio S; Tu JW; Vogt M; Savino AM; Silvestri D; Valsecchi MG; Biondi A; Borkhardt A; Bhatia S; Cazzaniga G; Fazio G; Bardini M; Palmi C
Biochem Pharmacol; 2023 Nov; 217():115809. PubMed ID: 37717691
[TBL] [Abstract] [Full Text] [Related]
5. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
[TBL] [Abstract] [Full Text] [Related]
7. Secondary involvement of gallbladder by acute lymphoblastic leukemia presenting clinically as cholecystitis in a young patient: a case report.
Rahim S; Ahmad Z; Chundriger Q; Ahmed A; Ali N; Abdul-Ghafar J
World J Surg Oncol; 2023 Feb; 21(1):63. PubMed ID: 36843105
[TBL] [Abstract] [Full Text] [Related]
8. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
[TBL] [Abstract] [Full Text] [Related]
9. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Sworder BJ; Kurtz DM; Alig SK; Frank MJ; Shukla N; Garofalo A; Macaulay CW; Shahrokh Esfahani M; Olsen MN; Hamilton J; Hosoya H; Hamilton M; Spiegel JY; Baird JH; Sugio T; Carleton M; Craig AFM; Younes SF; Sahaf B; Sheybani ND; Schroers-Martin JG; Liu CL; Oak JS; Jin MC; Beygi S; Hüttmann A; Hanoun C; Dührsen U; Westin JR; Khodadoust MS; Natkunam Y; Majzner RG; Mackall CL; Diehn M; Miklos DB; Alizadeh AA
Cancer Cell; 2023 Jan; 41(1):210-225.e5. PubMed ID: 36584673
[TBL] [Abstract] [Full Text] [Related]
10. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
[TBL] [Abstract] [Full Text] [Related]
11. pax5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
[TBL] [Abstract] [Full Text] [Related]
12. [The Application of RNA-Sequencing in Pediatric B-Cell Acute Lymphoblastic leukemia].
Zou PL; Liao X; Xiao JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1700-1707. PubMed ID: 36476892
[TBL] [Abstract] [Full Text] [Related]
13. [pax5-positive plasma cell leukemia presenting as lymphocytosis].
Tateno S; Hirao M; Kikuchi T; Tsukada Y; Kunieda H; Osada M; Yamazaki K; Denda R; Hirose S; Matsushita M; Ichikawa D; Hattori Y
Rinsho Ketsueki; 2022; 63(10):1415-1420. PubMed ID: 36351649
[TBL] [Abstract] [Full Text] [Related]
14. The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia.
Urbańska Z; Lejman M; Taha J; Madzio J; Ostrowska K; Miarka-Walczyk K; Wypyszczak K; Styka B; Jakubowska J; Sędek Ł; Szczepański T; Stańczak M; Fendler W; Młynarski W; Pastorczak A
Neoplasia; 2023 Jan; 35():100840. PubMed ID: 36288679
[TBL] [Abstract] [Full Text] [Related]
15. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
16. RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).
Rehn J; Mayoh C; Heatley SL; McClure BJ; Eadie LN; Schutz C; Yeung DT; Cowley MJ; Breen J; White DL
PLoS Genet; 2022 Oct; 18(10):e1010300. PubMed ID: 36251721
[TBL] [Abstract] [Full Text] [Related]
17. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
18. Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster.
Zeig-Owens R; Goldfarb DG; Luft BJ; Yang X; Murata K; Ramanathan L; Thoren K; Doddi S; Shah UA; Mueller AK; Hall CB; Giricz O; Verma A; Prezant DJ; Landgren O
Blood Cancer J; 2022 Aug; 12(8):120. PubMed ID: 35995768
[TBL] [Abstract] [Full Text] [Related]
19. pax5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
[TBL] [Abstract] [Full Text] [Related]
20. Correlates of common concerns in older cancer survivors of leukemia and lymphoma: results from the WHI LILAC study.
Loh KP; McLaughlin EM; Krok-Schoen JL; Odejide OO; El-Jawahri A; Qi L; Shadyab AH; Johnson LG; Paskett ED
J Cancer Surviv; 2023 Jun; 17(3):769-780. PubMed ID: 35982359
[TBL] [Abstract] [Full Text] [Related]
[Next]
